narciclasine has been researched along with Stomach Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, H; He, X; Li, X; Liu, Y; Shi, X; Tang, Y; Yuan, Y | 1 |
1 other study(ies) available for narciclasine and Stomach Neoplasms
| Article | Year |
|---|---|
Narciclasine induces autophagy-mediated apoptosis in gastric cancer cells through the Akt/mTOR signaling pathway.
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Phenanthridines; Proto-Oncogene Proteins c-akt; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases | 2021 |